Medical - Devices
Compare Stocks
5 / 10Stock Comparison
BRKR vs WAT vs TRMB vs FTV vs A
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Diagnostics & Research
Hardware, Equipment & Parts
Hardware, Equipment & Parts
Medical - Diagnostics & Research
BRKR vs WAT vs TRMB vs FTV vs A — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Devices | Medical - Diagnostics & Research | Hardware, Equipment & Parts | Hardware, Equipment & Parts | Medical - Diagnostics & Research |
| Market Cap | $6.44B | $22.78B | $15.02B | $18.59B | $33.31B |
| Revenue (TTM) | $3.46B | $3.77B | $3.69B | $4.74B | $7.07B |
| Net Income (TTM) | $-26M | $449M | $456M | $544M | $1.29B |
| Gross Margin | 45.3% | 55.0% | 68.8% | 61.8% | 38.8% |
| Operating Margin | 4.9% | 17.1% | 17.7% | 17.7% | 20.6% |
| Forward P/E | 20.0x | 24.3x | 20.5x | 20.4x | 19.7x |
| Total Debt | $2.04B | $1.41B | $1.39B | $3.21B | $3.35B |
| Cash & Equiv. | $299M | $588M | $253M | $376M | $1.79B |
BRKR vs WAT vs TRMB vs FTV vs A — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Bruker Corporation (BRKR) | 100 | 97.7 | -2.3% |
| Waters Corporation (WAT) | 100 | 174.9 | +74.9% |
| Trimble Inc. (TRMB) | 100 | 162.1 | +62.1% |
| Fortive Corporation (FTV) | 100 | 157.1 | +57.1% |
| Agilent Technologie… (A) | 100 | 133.5 | +33.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BRKR vs WAT vs TRMB vs FTV vs A
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BRKR lags the leaders in this set but could rank higher in a more targeted comparison.
WAT ranks third and is worth considering specifically for growth exposure.
- Rev growth 7.0%, EPS growth 0.5%, 3Y rev CAGR 2.1%
- 7.0% revenue growth vs FTV's -17.5%
Among these 5 stocks, TRMB doesn't own a clear edge in any measured category.
FTV is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.83, Low D/E 49.6%, current ratio 0.71x
- Beta 0.83 vs BRKR's 1.59, lower leverage
- +19.7% vs TRMB's +0.2%
A carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 10 yrs, beta 1.23, yield 0.8%
- 202.6% 10Y total return vs WAT's 163.2%
- PEG 1.34 vs TRMB's 8.35
- Beta 1.23, yield 0.8%, current ratio 1.96x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.0% revenue growth vs FTV's -17.5% | |
| Value | Lower P/E (19.7x vs 20.5x), PEG 1.34 vs 8.35 | |
| Quality / Margins | 18.3% margin vs BRKR's -0.8% | |
| Stability / Safety | Beta 0.83 vs BRKR's 1.59, lower leverage | |
| Dividends | 0.8% yield, 10-year raise streak, vs BRKR's 0.4%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +19.7% vs TRMB's +0.2% | |
| Efficiency (ROA) | 10.1% ROA vs BRKR's -0.4%, ROIC 13.5% vs 4.4% |
BRKR vs WAT vs TRMB vs FTV vs A — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BRKR vs WAT vs TRMB vs FTV vs A — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BRKR leads in 1 of 6 categories
FTV leads 1 • A leads 1 • WAT leads 0 • TRMB leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — TRMB and A each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
A is the larger business by revenue, generating $7.1B annually — 2.0x BRKR's $3.5B. A is the more profitable business, keeping 18.3% of every revenue dollar as net income compared to BRKR's -0.8%. On growth, WAT holds the edge at +91.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.5B | $3.8B | $3.7B | $4.7B | $7.1B |
| EBITDAEarnings before interest/tax | $339M | $953M | $785M | $1.1B | $1.7B |
| Net IncomeAfter-tax profit | -$26M | $449M | $456M | $544M | $1.3B |
| Free Cash FlowCash after capex | $51M | $264M | $253M | $971M | $993M |
| Gross MarginGross profit ÷ Revenue | +45.3% | +55.0% | +68.8% | +61.8% | +38.8% |
| Operating MarginEBIT ÷ Revenue | +4.9% | +17.1% | +17.7% | +17.7% | +20.6% |
| Net MarginNet income ÷ Revenue | -0.8% | +11.9% | +12.4% | +11.5% | +18.3% |
| FCF MarginFCF ÷ Revenue | +1.5% | +7.0% | +6.9% | +20.5% | +14.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.7% | +91.5% | +11.8% | -27.5% | +7.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -81.8% | -142.9% | +55.6% | -12.0% | -3.6% |
Valuation Metrics
BRKR leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 25.8x trailing earnings, A trades at a 29% valuation discount to TRMB's 36.2x P/E. Adjusting for growth (PEG ratio), A offers better value at 1.75x vs TRMB's 14.75x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $6.4B | $22.8B | $15.0B | $18.6B | $33.3B |
| Enterprise ValueMkt cap + debt − cash | $8.2B | $23.6B | $16.2B | $21.4B | $34.9B |
| Trailing P/EPrice ÷ TTM EPS | -282.00x | 32.48x | 36.24x | 34.71x | 25.75x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.01x | 24.30x | 20.52x | 20.39x | 19.71x |
| PEG RatioP/E ÷ EPS growth rate | — | 6.27x | 14.75x | — | 1.75x |
| EV / EBITDAEnterprise value multiple | 17.93x | 21.47x | 20.53x | 17.35x | 19.74x |
| Price / SalesMarket cap ÷ Revenue | 1.87x | 7.20x | 4.19x | 3.62x | 4.79x |
| Price / BookPrice ÷ Book value/share | 2.56x | 8.15x | 2.61x | 2.99x | 4.96x |
| Price / FCFMarket cap ÷ FCF | 148.71x | 42.21x | 112.79x | 19.01x | 28.92x |
Profitability & Efficiency
Evenly matched — WAT and A each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
A delivers a 18.7% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-1 for BRKR. TRMB carries lower financial leverage with a 0.24x debt-to-equity ratio, signaling a more conservative balance sheet compared to BRKR's 0.81x. On the Piotroski fundamental quality scale (0–9), FTV scores 6/9 vs WAT's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -1.1% | +8.0% | +8.0% | +7.4% | +18.7% |
| ROA (TTM)Return on assets | -0.4% | +4.6% | +5.0% | +4.1% | +10.1% |
| ROICReturn on invested capital | +4.4% | +20.3% | +6.8% | +6.0% | +13.5% |
| ROCEReturn on capital employed | +5.0% | +18.5% | +7.8% | +7.5% | +14.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 5 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.81x | 0.55x | 0.24x | 0.50x | 0.50x |
| Net DebtTotal debt minus cash | $1.7B | $820M | $1.1B | $2.8B | $1.6B |
| Cash & Equiv.Liquid assets | $299M | $588M | $253M | $376M | $1.8B |
| Total DebtShort + long-term debt | $2.0B | $1.4B | $1.4B | $3.2B | $3.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.75x | 6.72x | 12.26x | 6.67x | 19.53x |
Total Returns (Dividends Reinvested)
Evenly matched — TRMB and FTV each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WAT five years ago would be worth $11,311 today (with dividends reinvested), compared to $6,345 for BRKR. Over the past 12 months, FTV leads with a +19.7% total return vs TRMB's +0.2%. The 3-year compound annual growth rate (CAGR) favors TRMB at 10.1% vs BRKR's -17.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -12.0% | -8.5% | -19.0% | +9.2% | -14.3% |
| 1-Year ReturnPast 12 months | +7.7% | +3.1% | +0.2% | +19.7% | +12.8% |
| 3-Year ReturnCumulative with dividends | -44.4% | +17.9% | +33.4% | +25.1% | -9.0% |
| 5-Year ReturnCumulative with dividends | -36.6% | +13.1% | -16.5% | +12.7% | -7.7% |
| 10-Year ReturnCumulative with dividends | +59.6% | +163.2% | +172.8% | +103.5% | +202.6% |
| CAGR (3Y)Annualised 3-year return | -17.8% | +5.6% | +10.1% | +7.8% | -3.1% |
Risk & Volatility
FTV leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
FTV is the less volatile stock with a 0.83 beta — it tends to amplify market swings less than BRKR's 1.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FTV currently trades 96.2% from its 52-week high vs TRMB's 72.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.59x | 1.07x | 1.46x | 0.83x | 1.23x |
| 52-Week HighHighest price in past year | $56.22 | $414.15 | $87.50 | $62.81 | $160.27 |
| 52-Week LowLowest price in past year | $28.53 | $275.05 | $62.00 | $46.34 | $104.36 |
| % of 52W HighCurrent price vs 52-week peak | +75.2% | +84.4% | +72.5% | +96.2% | +73.4% |
| RSI (14)Momentum oscillator 0–100 | 52.6 | 62.7 | 55.6 | 57.1 | 52.2 |
| Avg Volume (50D)Average daily shares traded | 1.9M | 989K | 1.7M | 3.0M | 2.0M |
Analyst Outlook
A leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BRKR as "Buy", WAT as "Hold", TRMB as "Buy", FTV as "Hold", A as "Buy". Consensus price targets imply 49.8% upside for TRMB (target: $95) vs 0.4% for FTV (target: $61). For income investors, A offers the higher dividend yield at 0.84% vs BRKR's 0.36%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $52.13 | $402.57 | $95.00 | $60.67 | $166.00 |
| # AnalystsCovering analysts | 32 | 34 | 28 | 30 | 38 |
| Dividend YieldAnnual dividend ÷ price | +0.4% | — | — | +0.5% | +0.8% |
| Dividend StreakConsecutive years of raises | 0 | 1 | — | 0 | 10 |
| Dividend / ShareAnnual DPS | $0.15 | — | — | $0.29 | $0.99 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | +0.1% | +5.7% | +8.7% | +1.3% |
BRKR leads in 1 of 6 categories (Valuation Metrics). FTV leads in 1 (Risk & Volatility). 3 tied.
BRKR vs WAT vs TRMB vs FTV vs A: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BRKR or WAT or TRMB or FTV or A a better buy right now?
For growth investors, Waters Corporation (WAT) is the stronger pick with 7.
0% revenue growth year-over-year, versus -17. 5% for Fortive Corporation (FTV). Agilent Technologies, Inc. (A) offers the better valuation at 25. 8x trailing P/E (19. 7x forward), making it the more compelling value choice. Analysts rate Bruker Corporation (BRKR) a "Buy" — based on 32 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BRKR or WAT or TRMB or FTV or A?
On trailing P/E, Agilent Technologies, Inc.
(A) is the cheapest at 25. 8x versus Trimble Inc. at 36. 2x. On forward P/E, Agilent Technologies, Inc. is actually cheaper at 19. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Agilent Technologies, Inc. wins at 1. 34x versus Trimble Inc. 's 8. 35x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — BRKR or WAT or TRMB or FTV or A?
Over the past 5 years, Waters Corporation (WAT) delivered a total return of +13.
1%, compared to -36. 6% for Bruker Corporation (BRKR). Over 10 years, the gap is even starker: A returned +202. 6% versus BRKR's +59. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BRKR or WAT or TRMB or FTV or A?
By beta (market sensitivity over 5 years), Fortive Corporation (FTV) is the lower-risk stock at 0.
83β versus Bruker Corporation's 1. 59β — meaning BRKR is approximately 92% more volatile than FTV relative to the S&P 500. On balance sheet safety, Trimble Inc. (TRMB) carries a lower debt/equity ratio of 24% versus 81% for Bruker Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — BRKR or WAT or TRMB or FTV or A?
By revenue growth (latest reported year), Waters Corporation (WAT) is pulling ahead at 7.
0% versus -17. 5% for Fortive Corporation (FTV). On earnings-per-share growth, the picture is similar: Agilent Technologies, Inc. grew EPS 3. 2% year-over-year, compared to -119. 7% for Bruker Corporation. Over a 3-year CAGR, BRKR leads at 10. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BRKR or WAT or TRMB or FTV or A?
Waters Corporation (WAT) is the more profitable company, earning 20.
3% net margin versus -0. 3% for Bruker Corporation — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WAT leads at 28. 2% versus 6. 9% for BRKR. At the gross margin level — before operating expenses — TRMB leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BRKR or WAT or TRMB or FTV or A more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Agilent Technologies, Inc. (A) is the more undervalued stock at a PEG of 1. 34x versus Trimble Inc. 's 8. 35x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Agilent Technologies, Inc. (A) trades at 19. 7x forward P/E versus 24. 3x for Waters Corporation — 4. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TRMB: 49. 8% to $95. 00.
08Which pays a better dividend — BRKR or WAT or TRMB or FTV or A?
In this comparison, A (0.
8% yield), FTV (0. 5% yield), BRKR (0. 4% yield) pay a dividend. WAT, TRMB do not pay a meaningful dividend and should not be held primarily for income.
09Is BRKR or WAT or TRMB or FTV or A better for a retirement portfolio?
For long-horizon retirement investors, Agilent Technologies, Inc.
(A) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 23), 0. 8% yield, +202. 6% 10Y return). Bruker Corporation (BRKR) carries a higher beta of 1. 59 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (A: +202. 6%, BRKR: +59. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BRKR and WAT and TRMB and FTV and A?
These companies operate in different sectors (BRKR (Healthcare) and WAT (Healthcare) and TRMB (Technology) and FTV (Technology) and A (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
A pays a dividend while BRKR, WAT, TRMB, FTV do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.